CA2473586A1 — Treatment of sleep disorders using sleep target modulators
Assigned to Hypnion Inc · Expires 2003-08-21 · 23y expired
What this patent protects
The invention is directed to compositions used for treating sleep disorders. In addition, the invention provides convenient methods of treatment of a sle ep disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for…
USPTO Abstract
The invention is directed to compositions used for treating sleep disorders. In addition, the invention provides convenient methods of treatment of a sle ep disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of tim e to reduce side effects. More specifically, the invention is directed to the compositions and use of ester derivatized trazodone compounds for the treatment of sleep disorders.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.